Executive Director / CEO
This analysis benchmarks the total compensation of Michael Poon, Executive Director / CEO ($200,000) against every comparable organization that fit the selection criteria — 29 in total — drawn systematically from IRS Form 990 filings, not a hand-picked subset.
Compensation sits at approximately the 97th percentile of comparable organizationsabove the 90th percentile — board review recommended
Benchmarked executive: Michael Poon — reported title “Principal Investigator”, selected as the organization's highest-paid individual — no exact title match, so confirm this is a comparable role.
Each figure is Form 990 Part VII columns D + F (reportable pay plus other compensation and benefits; column F may include amounts from related organizations), normalized to NY cost of living (BEA RPP, 2023) and to its filing year (CPI-U); the reported amount is on each linked 990.
| Organization | State | Revenue | Matched title | Comp (reported) | Comp (adjusted) | FY |
|---|---|---|---|---|---|---|
| Post-finasteride Syndrome Foundation | NJ | $91,449 | President | $24,000 | $23,033 | 2024 |
| Northeast Osteopathic Medical | ME | $90,000 | Executive Di | $180,075 | $199,548 | 2023 |
| Beth Israel Deaconess Department Of | MA | $89,438 | Director (Ex-officio) (Hmfp Ceo) | $109,829 | $106,086 | 2024 |
| The Tiller Foundation | AZ | $93,604 | President & Director | $24,000 | $25,543 | 2023 |
| Rpa Research & Education Foundation | MD | $87,336 | Executive Director | $17,583 | $17,670 | 2024 |
| The Parkinson Alliance Inc | NJ | $85,580 | President & Ceo | $57,692 | $55,368 | 2024 |
| Val Skinner Foundation Inc | NJ | $96,009 | Chairperson | $7,500 | $7,198 | 2024 |
| Xeroderma Pigmentosum Family Support | CA | $85,358 | Co-executive Director | $25,000 | $23,205 | 2024 |
| Arizona Infectious Disease Society Inc | AZ | $84,010 | President | $6,900 | $7,133 | 2024 |
| The International Genomics Consortium | AZ | $83,902 | Ceo | $663,981 | $706,670 | 2023 |
| Children's Cancer Aid And Research Institute | AZ | $98,592 | President | $29,575 | $30,573 | 2024 |
| Anchorage York Rite Foundation Inc | AK | $102,219 | Secretarytreasurer | $5,680 | $5,837 | 2024 |
| Tri County Development Corp | TN | $102,667 | President/ceo | $8,413 | $9,506 | 2024 |
| Allergists For Israel | OH | $106,610 | Administrator | $3,250 | $3,700 | 2024 |
| The Alliance For Benzodiazepine Best Practices | OR | $109,326 | Medical Director | $24,000 | $24,665 | 2023 |
| Northwell Health Medical Pa Pc | NY | $71,513 | Ceo | $75,656 | $73,485 | 2024 |
| The Salgi Esophageal Cancer Research Foundation | RI | $110,298 | Vice President | $8,800 | $9,071 | 2024 |
| University Kidney Research Organization | CA | $110,733 | President | $2,000 | $1,857 | 2024 |
| Heart And Stroke Research Fund | AZ | $112,297 | President | $2,000 | $2,015 | 2025 |
| Ghost Tree Invitational Ltd | OR | $112,403 | Vice Preside | $12,000 | $11,979 | 2024 |
| The Healthy Birth And Infant Brains | WY | $67,642 | Executive Director | $20,000 | $23,020 | 2024 |
| Detroit International Research And | MI | $116,460 | Executive Di | $25,992 | $28,837 | 2024 |
| Vincera Foundation | PA | $116,830 | Executive Dir. | $30,000 | $32,158 | 2024 |
| The Valhalla Fund | WA | $119,578 | Ceo | $18,342 | $17,652 | 2024 |
| Foundation For Arthroplasty Research And | IL | $119,978 | Executive Director | $24,514 | $26,670 | 2023 |
Comp (reported) is the figure on each organization's Form 990 (columns D + F); Comp (adjusted) normalizes it to NY cost of living and 2023 dollars. Click any organization to verify the figure on ProPublica.
Comparable organizations were drawn from electronically filed IRS Form 990 returns and matched on sector (NTEE code), budget (a size-adaptive revenue band that tightens as the organization grows), and geography (same-state first, broadening only when too few peers qualify); every organization within the band forms the peer set. To compare fairly across regions and years, peer compensation is normalized to NY cost of living (BEA Regional Price Parities, 2023) and to the subject's filing year (CPI-U). The figure benchmarked is Form 990 Part VII, Section A, columns D + F — reportable pay plus other compensation, benefits, and deferred amounts (column F may include amounts from related organizations) — with the chief executive matched by role. Related-organization amounts (column E) and institutional trustees are excluded. Full methodology: peerbasis.org/methodology.
Sensitivity — the subject's percentile under alternative compensation definitions:
| Basis | Subject percentile |
|---|---|
| Total compensation (D + F), cost-of-living + inflation adjusted — the PeerBasis default | 97th |
| Total compensation (D + F), as reported (no adjustments) | 97th |
| Reportable pay only (column D), adjusted | 97th |
| All sources (D + E + F), adjusted | 83rd |
If the percentile moves materially across these definitions, the result is sensitive to methodology choices, and the board should weigh which basis best fits its facts.
Compensation paid by a tax-exempt organization is presumed reasonable — shifting the burden to the IRS — when three requirements are met. This report supplies the comparability data for the second. The board should record the following in its minutes concurrently with its decision:
Draft board minutes — executive compensation
Sources: IRS Form 990 e-file data (apps.irs.gov); IRS Business Master File (NTEE classification). Every figure traces to an original public filing — click any organization above to verify it on ProPublica. PeerBasis is a service of Prismind Analytics; its methodology is published, was commissioned for independent adversarial review, and discloses its own limitations. This report is comparability data to support a board's good-faith determination under IRC 4958; it is not legal or tax advice. Generated by PeerBasis on June 9, 2026.